While our study observed certain molecular characteristics associated with IBC, including a higher frequency of HER2-enriched and Luminal B subtypes, mutant-like P53, and high HRD, the overall limited number of IBC cases and significant DEGs, and the lack of a distinct immune profile, failed to replicate results from early studies. Here, ERBB2 is linked to inflammatory breast carcinoma.